Cargando…

Depressive Symptoms and PANSS Symptom Dimensions in Patients With Predominant Negative Symptom Schizophrenia: A Network Analysis

INTRODUCTION: Schizophrenia is a severe psychiatric disorder with a large symptomatic heterogeneity. Moreover, many patients with schizophrenia present with comorbid psychiatric symptoms or disorders. The relation between depressive symptoms and negative symptoms, such as blunted affect, alogia, anh...

Descripción completa

Detalles Bibliográficos
Autores principales:	Demyttenaere, Koen, Anthonis, Elizabeth, Acsai, Károly, Correll, Christoph U.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Psychiatry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9081724/ https://www.ncbi.nlm.nih.gov/pubmed/35546936 http://dx.doi.org/10.3389/fpsyt.2022.795866

Ejemplares similares

Disentangling the symptoms of schizophrenia: Network analysis in acute phase patients and in patients with predominant negative symptoms
por: Demyttenaere, Koen, et al.
Publicado: (2021)

What Is the Minimum Clinically Important Change in Negative Symptoms of Schizophrenia? PANSS Based Post-hoc Analyses of a Phase III Clinical Trial
por: Czobor, Pál, et al.
Publicado: (2022)

Linking PANSS negative symptom scores with the Clinical Global Impressions Scale: understanding negative symptom scores in schizophrenia
por: Leucht, Stefan, et al.
Publicado: (2019)

Negative symptom dimensions and social functioning in Chinese patients with schizophrenia
por: Gao, Tianqi, et al.
Publicado: (2022)

S48. INTER-RATER RELIABILITY OF PANSS-6 SCHIZOPHRENIA SEVERITY RATINGS OBTAINED USING THE SIMPLIFIED NEGATIVE AND POSITIVE SYMPTOMS INTERVIEW (SNAPSI)
por: Kølbæk, Pernille, et al.
Publicado: (2018)

Assessment and correlates of autistic symptoms in Schizophrenia Spectrum Disorders measured with the PANSS Autism Severity Score: A systematic review
por: Nibbio, Gabriele, et al.
Publicado: (2022)

Patterns of schizophrenia symptoms: hidden structure in the PANSS questionnaire
por: Lefort-Besnard, Jérémy, et al.
Publicado: (2018)

The Correlation of Positive and Negative Symptoms (PANSS Scores) in Patients with Schizophrenia According to Gender
por: Sulejmanpasic, Gorana, et al.
Publicado: (2023)

Case Report: Cariprazine Efficacy in Young Patients Diagnosed With Schizophrenia With Predominantly Negative Symptoms
por: Vasiliu, Octavian
Publicado: (2021)

Brain Structural Signatures of Negative Symptoms in Depression and Schizophrenia
por: Chuang, Jie-Yu, et al.
Publicado: (2014)

Improving Mood and Cognitive Symptoms in Huntington's Disease With Cariprazine Treatment
por: Molnar, Maria Judit, et al.
Publicado: (2022)

Primary and Secondary Negative Symptoms in Schizophrenia
por: Mosolov, Sergey N., et al.
Publicado: (2022)

T111. PANSS NEGATIVE SYMPTOM DIMENSIONS ACROSS GEOGRAPHICAL REGIONS: IMPLICATIONS FOR SOCIAL, LINGUISTIC AND CULTURAL CONSISTENCY
por: Khan, Anzalee, et al.
Publicado: (2018)

T109. CLUSTERING OF SCHIZOPHRENIA PATIENT SUBTYPES BY SPECIFIC SYMPTOM DIMENSIONS USING AN UNCORRELATED PANSS SCORE MATRIX (UPSM)
por: Hopkins, Seth, et al.
Publicado: (2018)

A Bioecosystem Theory of Negative Symptoms in Schizophrenia
por: Strauss, Gregory P.
Publicado: (2021)

Structure of Negative Symptoms in Schizophrenia: An Unresolved Issue
por: Russo, Manuela, et al.
Publicado: (2021)

The Relationship Between Cognitive Dysfunction and Symptom Dimensions Across Schizophrenia, Bipolar Disorder, and Major Depressive Disorder
por: Zhu, Yue, et al.
Publicado: (2019)

S49. EFFICACY OF HIGH-FREQUENCY REPETITIVE TRANSCRANIAL MAGNETIC STIMULATION ON PANSS FACTORS IN SCHIZOPHRENIA WITH PREDOMINANT NEGATIVE SYMPTOMS – RESULTS FROM AN EXPLORATORY RE-ANALYSIS
por: Hansbauer, Maximilian, et al.
Publicado: (2018)

Autism Spectrum Disorder and Schizophrenia Are Better Differentiated by Positive Symptoms Than Negative Symptoms
por: Trevisan, Dominic A., et al.
Publicado: (2020)

S46. THE VALIDITY AND SENSITIVITY OF PANSS-6 IN TREATMENT-RESISTANT SCHIZOPHRENIA
por: Ostergaard, Soren Dinesen, et al.
Publicado: (2018)

Prediction Analysis for Transition to Schizophrenia in Individuals at Clinical High Risk for Psychosis: The Relationship of DAO, DAOA, and NRG1 Variants with Negative Symptoms and Cognitive Deficits
por: Jagannath, Vinita, et al.
Publicado: (2017)

The Impact of Negative Symptoms and Neurocognition on Functioning in MDD and Schizophrenia
por: Quek, Yue Feng, et al.
Publicado: (2021)

Corrigendum: Structure of Negative Symptoms in Schizophrenia: An Unresolved Issue
por: Russo, Manuela, et al.
Publicado: (2022)

Optimal cutoff scores of the Chinese version of 15-item negative symptom assessment that indicate prominent negative symptoms of schizophrenia
por: Zhou, Qi, et al.
Publicado: (2023)

Reinforcement Learning and Dopamine in Schizophrenia: Dimensions of Symptoms or Specific Features of a Disease Group?
por: Deserno, Lorenz, et al.
Publicado: (2013)

Psychosis and Schizophrenia-Spectrum Personality Disorders Require Early Detection on Different Symptom Dimensions
por: Schultze-Lutter, Frauke, et al.
Publicado: (2019)

Synthetic Cannabinoids and Its Association With Persistent Negative Symptoms of Schizophrenia
por: Satodiya, Ritvij, et al.
Publicado: (2020)

Assessment and Treatment of Negative Symptoms in Schizophrenia—A Regional Perspective
por: Bitter, Istvan, et al.
Publicado: (2022)

Impact of negative symptoms on health-related quality of life in schizophrenia
por: Li, Yanhui, et al.
Publicado: (2023)

Dietary Glutamic Acid, Obesity, and Depressive Symptoms in Patients With Schizophrenia
por: Kumar, Pooja, et al.
Publicado: (2021)

Negative Symptoms in Schizophrenia: A Review and Clinical Guide for Recognition, Assessment, and Treatment
por: Correll, Christoph U, et al.
Publicado: (2020)

Attachment Dimensions predict Social Functioning in persons with Schizophrenia-Spectrum Disorders, regardless of Symptom Severity
por: Cristina, Monfort-Escrig, et al.
Publicado: (2021)

Trajectories of adaptive and disturbed identity dimensions in adolescence: developmental associations with self-esteem, resilience, symptoms of depression, and borderline personality disorder features
por: Bogaerts, Annabel, et al.
Publicado: (2023)

Magnetic Resonance Imaging in Studying Schizophrenia, Negative Symptoms, and the Glutamate System
por: Gruber, Oliver, et al.
Publicado: (2014)

Clinical Correlates of Insulin Resistance in Chronic Schizophrenia: Relationship to Negative Symptoms
por: Soontornniyomkij, Virawudh, et al.
Publicado: (2019)

Inflammation and Negative Symptoms of Schizophrenia: Implications for Reward Processing and Motivational Deficits
por: Goldsmith, David R., et al.
Publicado: (2020)

Real-World Functioning in Patients With Schizophrenia: Beyond Negative and Cognitive Symptoms
por: García-Portilla, María Paz, et al.
Publicado: (2021)

Association Between Abundance of Haemophilus in the Gut Microbiota and Negative Symptoms of Schizophrenia
por: Zhu, Cuizhen, et al.
Publicado: (2021)

Use of Bupropion in the Management of Negative Symptom Schizophrenia: A Case Series
por: Perera, Pradilka, et al.
Publicado: (2022)

Obsessive-compulsive symptoms in patient with schizophrenia: The influence of disorganized symptoms, duration of schizophrenia, and drug resistance
por: Panov, Georgi, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_s911rj8jipmqmaua3u4rjiag0g